Sheets Smith Wealth Management’s Biogen BIIB Stock Holding History

Sheets Smith Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-4,663	Closed	-$1.88M	–	215
2015 Q2	$1.88M	Buy	4,663 +89	+2%	+$35.7K	0.51%	56
2015 Q1	$1.93M	Sell	4,574 -75	-2%	-$29.6K	0.53%	55
2014 Q4	$1.58M	Sell	4,649 -276	-6%	-$89.3K	0.41%	71
2014 Q3	$1.63M	Buy	4,925 +298	+6%	+$98.3K	0.44%	68
2014 Q2	$1.46M	Buy	4,627 +1,059	+30%	+$319K	0.39%	73
2014 Q1	$1.09M	Buy	3,568 +511	+17%	+$162K	0.31%	88
2013 Q4	$855K	Buy	3,057 +209	+7%	+$54.1K	0.24%	110
2013 Q3	$686K	Buy	+2,848	New	+$637K	0.22%	125

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Sheets Smith Wealth Management's BIIB Position: Q3 2015 in Review

Sheets Smith Wealth Management sold out of Biogen (BIIB) in Q3 2015, closing a stake of 4,663 shares — an estimated $1.88M sold.

Sheets Smith Wealth Management first reported a position in BIIB in Q3 2013 and held it in 8 quarters. The position peaked at $1.93M in Q1 2015. 924 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

Sheets Smith Wealth Management reported no remaining Biogen position as of Q3 2015 after selling out during the quarter.
Sheets Smith Wealth Management sold 4,663 Biogen shares in Q3 2015, an estimated $1.88M.
Sheets Smith Wealth Management first reported a position in Biogen in Q3 2013 and held it in 8 quarters.
Sheets Smith Wealth Management's Biogen position peaked at $1.93M in Q1 2015.
924 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on Sheets Smith Wealth Management's 13F filing for Q3 2015, filed 13 Nov 2015.